HomeNews

News

Inactivation of Suv39h1 Enhances Anti-Tumor Immune Response by Increasing T Cell Activity

Mnemo Therapeutics, a biotechnology company developing transformational immunotherapies, today announced a publication in Nature Communications demonstrating that the histone lysine methyltransferase enzyme Suv39h1 plays...

ClearMind Biomedical Clears FIM Clinical Trial for Least Invasive ICH Treatment to Date

ClearMind Biomedical's novel neurosurgical endoscope, the Axonpen System, has completed its First in Man (FIM) clinical trial in Taiwan with outstanding results. The Axonpen System...

Billion-Euro Market Biotechnology: Exyte Builds mRNA Competence Center for WACKER in Halle

Exyte GmbH (Exyte), a global leader in the design, engineering and delivery of facilities for high-tech industries, is building a mRNA competence center at...

Nokia wins five-year nationwide 5G deal with Ice Norway

Nokia wins five-year nationwide 5G deal with Ice Norway Deal to upgrade and expand footprint of 5G networks across Norway Nokia’s energy-efficient AirScale portfolio...

Cato Networks Expands SASE Presence in the Nordics with New Point of Presence (PoP) in Copenhagen

Adding its second Nordic PoP in Copenhagen, Cato bolsters resiliency and extends converged security and networking capabilities across the region  Cato Networks, provider of the world's first...
0FansLike
0FollowersFollow
spot_img

Hot Topics